A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Catapres Indications, Dosage, Storage, Stability - Clonidine HCL
Catapres Indications, Dosage, Storage, Stability - Clonidine HCL
INDICATIONS
Clonidine hydrochloride
is indicated in the treatment
of hypertension. Clonidine hydrochloride
may be employed alone or concomitantly with other antihypertensive
agents.
DOSAGE AND ADMINISTRATION
Adults: The dose
of clonidine hydrochloride
must be adjusted according to the patient’s individual blood
pressure response.
The following is a general guide
to its administration.
Initial Dose: 0.1 mg
tablet twice daily (morning
and bedtime). Elderly patients may benefit
from a lower initial
dose.
Maintenance Dose: Further increments of 0.1 mg
per day may be made at weekly
intervals if necessary until the desired response
is achieved. Taking the larger portion of the oral
daily dose at bedtime may
minimize transient adjustment
effects of dry mouth and
drowsiness. The therapeutic doses most commonly employed have ranged
from 0.2 mg to 0.6 mg
per day given in divided
doses. Studies have indicated that 2.4 mg
is the maximum effective daily dose, but doses as high as this have
rarely been employed.
Renal Impairment: Dosage must be adjusted according to the
degree of impairment,
and patients should be carefully monitored. Since only a minimal
amount of clonidine is removed during routine hemodialysis,
there is no need
to give supplemental
clonidine following dialysis.
HOW SUPPLIED
Catapres® (clonidine hydrochloride USP) is supplied in scored oval tablets containing 0.1 mg, 0.2 mg or 0.3
mg of clonidine hydrochloride.
|
Dose (mg)
|
Color
|
Marking
|
Bottle of 100
|
Bottle of 1000
|
Unit Dose of 100
|
|
0.1
|
Tan
|
BI 6
|
NDC0597-0006-01
|
NDC0597-0006-10
|
NDC0597-0006-61
|
|
0.2
|
Orange
|
BI 7
|
NDC0597-0007-01
|
NDC0597-0007-10
|
NDC0597-0007-61
|
|
0.3
|
Peach
|
BI 11
|
NDC0597-0011-01
|
|
|
Store at 25°C (77°F).
Excursions permitted to 15-30°C (59-86°F).
(See USP controlled room temperature).
Dispense in tight, light-resistant container.
Distributed by
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT 06877
Manufactured by
Promeco S.A. de C.V./(Boehringer Ingelheim-México)
México City, D.F.
Licensed from
Boehringer Ingelheim
International GmbH
Printed in U.S.A. Revised 4/98
top
